Clinical Trials Sponsored by Marius Aliuskevicius

Total 3648 results

Marius Aliuskevicius
University of Aarhus

Completed

Non Steroidal Antiinflammatory Drugs Influence on Heal of Distal Radius Fracture (CHIP)

Forearm Fracture

Denmark
Marius Pharmaceuticals
Syneos Health

Completed

Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men

Hypogonadism, Male

United States
Marcus Migura
Mercy Health

Completed

A Transparent Elasticized Adhesive Occlusive Compression Bandage for Use as an Arterial Tourniquet

Hemorrhage | Vascular Injury

United States
Marinus Pharmaceuticals

Recruiting

Randomized Therapy In Status Epilepticus (RAISE)

Status Epilepticus

United States, Australia, Canada
Marinus Pharmaceuticals

Enrolling by invitation

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

Tuberous Sclerosis Complex

United States, Spain, United Kingdom, Australia, China, Italy, Israel, Germany, France, Canada, Belgium
Marinus Pharmaceuticals

Completed

A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression

Behavioral Symptoms | Depressive Disorder | Depression | Mood Disorders | Pregnancy Complications | Depression, Postpartum | Mental Disorder | Postpartum Disorder | PPD | Postpartum Blues

United States
Marinus Pharmaceuticals

Completed

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

Infantile Spasms

United States
Marinus Pharmaceuticals

Completed

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B) (TSC)

Tuberous Sclerosis

United States
Marinus Pharmaceuticals

Completed

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601 (0602)

Epilepsy, Complex Partial

United States
Marius Pharmaceuticals
Syneos Health

Completed

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men

Hypogonadism, Male

United States
Marinus Pharmaceuticals

Recruiting

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy (TrustTSC)

Tuberous Sclerosis Complex

United States, Spain, Israel, United Kingdom, Germany, Canada, France, Italy
Marinus Pharmaceuticals

Not yet recruiting

Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old

CDKL5 Deficiency Disorder
Marinus Pharmaceuticals

Terminated

A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures

Drug Resistant Partial Onset Seizure

United States
Marinus Pharmaceuticals

Terminated

Open-label Extension to Protocol 1042-0500

Infantile Spasms

United States
Marinus Pharmaceuticals

Completed

Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder (Marigold)

CDKL5 Deficiency Disorder

United States, Australia, France, Israel, Italy, Poland, Russian Federation, United Kingdom
Marinus Pharmaceuticals

Completed

Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies

Epilepsy

United States, Italy
Marinus Pharmaceuticals

Completed

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Partial Epilepsy | Catamenial Epilepsy

United States
Marinus Pharmaceuticals

Completed

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Drug Resistant Partial Onset Seizure

United States, Australia, Russian Federation, Bulgaria, Germany, Poland
Marinus Pharmaceuticals

Completed

Open-label Extension to Protocol 1042-0600

Epilepsies, Partial

United States
Marinus Pharmaceuticals

Not yet recruiting

To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

Refractory Status Epilepticus

Spain, Switzerland, Germany, France, Austria, Italy, United Kingdom, Czechia, Croatia, Finland, Belgium, Lithuania, Hungary, Israel, Denmark
Marinus Pharmaceuticals

Withdrawn

Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)

Status Epilepticus

United States
Marinus Pharmaceuticals

No longer available

Ganaxolone Expanded Access Program Compassionate Use (CDD)

CDKL5 Disorder
Marinus Pharmaceuticals

Completed

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression

Behavioral Symptoms | Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Pregnancy Complications | Depression, Postpartum | Puerperal Disorders | Postpartum | PPD

United States
Marinus Pharmaceuticals

Completed

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

PCDH19-Related Epilepsy

United States, Hungary, Italy, Netherlands, Poland
Marinus Pharmaceuticals

Completed

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

Epilepsy | Status Epilepticus | Convulsive Status EPILEPTICUS | Non Convulsive Status Epilepticus

United States
Marius Henriksen

Completed

Progressive Active Exercise After Surgical Rotator Cuff Repair

Rotator Cuff Tear

Denmark
Marius Henriksen

Completed

Technology Assisted Physical Activity Among Hospitalised Patients With Respiratory Disease (TAPAS)

Respiratory Disease

Denmark
Marius Henriksen

Completed

Digital Motivation to Decrease Inactive Behaviour in Patients With Knee Osteoarthritis

Knee Osteoarthritis

Denmark
Marius Henriksen

Recruiting

Metformin Treatment of Patients With Hand Osteoarthritis (METRO)

Hand Osteoarthritis

Denmark
Marius Henriksen

Active, not recruiting

Intensive Diet vs Knee Arthroplasty for Knee Osteoarthritis (INKA)

Knee Osteoarthritis

Denmark
Marius Henriksen

Completed

Technology Assisted Physical Activity Among Hospitalised Medical Patients (TAPAS-2)

Pulmonary Disease | Cardiac Disease | Geriatric Disease

Denmark
Marius Henriksen

Completed

Comparison of Exercise Therapies for Patellofemoral Pain (COMPETE)

Patellofemoral Pain Syndrome

Denmark
Marius Henriksen

Completed

Saline Injections vs Education and Exercise in Knee Osteoarthritis (DISCO)

Osteoarthritis, Knee

Denmark
Marius Henriksen

Completed

Knee Replacement Outcome Predicted by Physiotherapists

Osteoarthritis | Total Knee Replacement

Denmark
Clarice Maria de Lucena Martins

Completed

Effect of a Multicomponent Intervention in Children and Adolescents

Metabolic Diseases | Physical Activity
Marius Henriksen

Completed

Cannabidiol for Fibromyalgia (The CANNFIB Trial) (CANNFIB)

Fibromyalgia

Denmark
Marius Henriksen

Completed

Characteristics of Patients Declining INKA Trial Participation (n-INKA)

Knee Osteoarthritis

Denmark
Marius Henriksen

Terminated

SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy (SMILE)

Liver Cirrhosis, Alcoholic

Denmark
Marius Henriksen

Terminated

Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure (TOCIVID)

Corona Virus Disease

Denmark
Marius Henriksen

Completed

Blood Pressure Changes During Moderate Intensity Strength Training in Aortic Stent-graft Patients

Aortic Stent Graft

Denmark
Marius Henriksen

Completed

Stretching and Pain Sensitivity

Stretching

Denmark
Marie Kristine Jessen, MD
Aarhus University Hospital; University of Aarhus; Viborg Regional Hospital; Randers...

Completed

Restrictive Fluid Administration vs. Standard of Care in Emergency Department Sepsis Patients (REFACED Sepsis)

Sepsis

Denmark
Marius Gustav Bredell

Unknown

Hypoxia Analysis in Head and/or Neck Cancer

Head and Neck Cancer

Switzerland
Markus Schlemmer

Recruiting

Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability

Anxiety Symptoms

Switzerland
Indiana University
Karius, Inc.

Completed

Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections (KDG-002)

Osteomyelitis | Septic Arthritis | Musculoskeletal Infection | Acute Hematogenous Osteomyelitis | Pyomyositis

United States
Karius, Inc.
Stanford University

Completed

Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients

Neutropenia | Fever

United States
Karius, Inc.
Duke University

Completed

Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay

Bacteremia | Septicemia

United States
Karius, Inc.
Stanford University

Completed

SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay

Sepsis

United States
Karius, Inc.
Stanford University

Completed

Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay

Neutropenia | Infection

United States
University of Aarhus
Aarhus University Hospital; Aarhus County, Denmark

Completed

Treatment of Patients With Longstanding Unexplained Health Complaints

Somatization Disorder

Denmark

Clinical Trials Sponsored by Marius Aliuskevicius

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations